[1]
“Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant”, FE, vol. 22, no. 1S, Apr. 2021, doi: 10.7175/fe.v22i1S.1486.